Imetelstat Shows Promising Results for Lower-Risk MDS in a Phase 2 Trial

Dr. Rami Komrokji, Vice Chair of the Malignant Hematology Program, is a joint senior author on a high-impact paper recently published in The Lancet.

Benefits of Prostatic Artery Embolization in Prostate Cancer Treatment

Dr. Nainesh Parikh, assistant chief Medical officer and interventional radiologist, joined the BackTable Podcast to discuss patient outcomes...

Dr. Jose Pimiento Appointed American College of Surgeons Commission on Cancer State Chair

Dr. Jose Pimiento was appointed state chair of the American College of Surgeons Commission on Cancer (CoC) Cancer Liaison Program.

Dr. Arnold Etame Receives NIH R01 Award for Novel Research

Dr. Arnold Etame has received an NIH R01 Award for his novel research "Targeting Malignant Reprogramming of Glioblastoma Stem Cells Through Dual...

Dr. Kim Presents Research Findings Investigating the Use of Regorafenib in mCRC

Richard Kim, MD, a senior member of the Gastrointestinal Oncology Program, recently presented at the 2024 Gastrointestinal Cancer Symposium.

Head and Neck-Endocrine Program’s Multidisciplinary Model Offers Patients Enhanced Treatment

The Head and Neck-Endocrine Oncology Program offers a multidisciplinary model that involves specialists from various fields seeing a patient...

Artificial Intelligence is Helping Deliver Cancer Outcomes Better than the National Average

Nowhere are we exploring AI, and its subcategory machine learning (ML), with more important consequences than the field of oncology.

Why We Built the First Machine Learning Department in Oncology

The resurgence of AI and its machine learning algorithms has created tremendous excitement for AI/ML prospects in cancer research.

The Future of Ovarian Cancer Treatment with Antibody-Drug Conjugates (ADCs)

The relentless pursuit of improving treatment for ovarian cancer has led to better outcomes and created new standards of care for ovarian cancer.

Chimeric RNAs Reveal Putative Neoantigen Peptides for Developing Tumor Vaccines for Breast Cancer

Dr. Brian Czerniecki, chair of the Breast Oncology Program, co-authored the publication, “Chimeric RNAs reveal putative neoantigen peptides for...

Response Assessment in Neuro-Oncology Criteria for Gliomas

Dr. Michael Vogelbaum co-authored a publication entitled, “RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and...

Balancing Benefits and Toxicity of Immunotherapy in Melanoma

Drs. Peter Forsyth and Muhammad Jaffer co-authored the publication entitled, “A Brain, A Heart, and the Courage: Balancing Benefit and Toxicity of...

Improving Brain Metastases Outcomes Through SRS and Targeted Therapies

Members of the Neuro-Oncology team co-authored a publication entitled, “Improving Brain Metastases Outcomes Through Therapeutic Synergy Between...

Impact of Surgical Margin and Extent of Lymphadenectomy on Oncologic Outcomes in Plasmacytoid Urothelial Carcinoma

“Impact of Surgical Margin and Extent of Lymphadenectomy on Oncologic Outcomes in Plasmacytoid Urothelial Carcinoma” explores guideline...

Immunotherapy in the Treatment of Localized Genitourinary Cancers

Urologists in the Department of Genitourinary Oncology co-authored the publication, "Immunotherapy in the Treatment of Localized Genitourinary...

Clinical Perspectives